Recruiting HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921 Conditions Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more Locations Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States View Trial Details
Recruiting Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662 Conditions Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Bone Marrow Diseases, +32 more Locations Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States View Trial Details
